ViroCyt Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $17.2M

ViroCyt General Information

Description

Developer of rapid quantification technology for viruses. The company provides the tools that deliver biotechnology processes such as vaccine manufacturing, protein expression and antiviral development for vaccine companies, bio-technologies, domestic and foreign government research institutes and universities.

Contact Information

Website
www.virocyt.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Technology Drive
  • Suite 325-C
  • Broomfield, CO 80021
  • United States
+1 (720)
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Acquirer
Sartorius
Vertical(s)
Life Sciences
Corporate Office
  • 100 Technology Drive
  • Suite 325-C
  • Broomfield, CO 80021
  • United States
+1 (720)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ViroCyt Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 15-Jul-2016 $17.2M Completed Generating Revenue
3. Early Stage VC 29-Apr-2015 Completed Generating Revenue
2. Early Stage VC 09-Jan-2015 $3.47M $11.7M Completed Generating Revenue
1. Early Stage VC (Series B) 10-Apr-2013 $8.2M $8.2M Completed Generating Revenue
To view ViroCyt’s complete valuation and funding history, request access »

ViroCyt Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of rapid quantification technology for viruses. The company provides the tools that deliver biotechnology proc
Biotechnology
Broomfield, CO
11 As of 2016

Saint Louis, MO
 

Shanghai, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ViroCyt Competitors (31)

One of ViroCyt’s 31 competitors is Leinco Technologies, a Private Equity-Backed company based in Saint Louis, MO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Leinco Technologies Private Equity-Backed Saint Louis, MO
WuXi AppTec Formerly PE-Backed Shanghai, China
Healx Venture Capital-Backed Cambridge, United Kingdom
Proteochem Corporation Hurricane, UT
Lonza Group Corporation Basel, Switzerland
You’re viewing 5 of 31 competitors. Get the full list »

ViroCyt Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ViroCyt Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
High Country Venture Venture Capital Minority
InDevR VC-Backed Company Majority
Angel (individual) Minority
To view ViroCyt’s complete investors history, request access »

Ready to get started?

Request a free trial

ViroCyt FAQs

  • When was ViroCyt founded?

    ViroCyt was founded in 2012.

  • Where is ViroCyt headquartered?

    ViroCyt is headquartered in Broomfield, CO.

  • What is the size of ViroCyt?

    ViroCyt has 11 total employees.

  • What industry is ViroCyt in?

    ViroCyt’s primary industry is Biotechnology.

  • Is ViroCyt a private or public company?

    ViroCyt is a Private company.

  • What is the current valuation of ViroCyt?

    The current valuation of ViroCyt is .

  • What is ViroCyt’s current revenue?

    The current revenue for ViroCyt is .

  • How much funding has ViroCyt raised over time?

    ViroCyt has raised $15.7M.

  • Who are ViroCyt’s investors?

    High Country Venture, InDevR, and have invested in ViroCyt.

  • Who are ViroCyt’s competitors?

    Leinco Technologies, WuXi AppTec, Healx, Proteochem, and Lonza Group are some of the 31 competitors of ViroCyt.

  • When was ViroCyt acquired?

    ViroCyt was acquired on 15-Jul-2016.

  • Who acquired ViroCyt?

    ViroCyt was acquired by Sartorius.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »